The FDA has determined that Johnson & Johnson’s McNeil Consumer Healthcare is responsible for failing to properly test their Tylenol pain reliever for contamination after a number consumer complaints in 2008. After receiving over 70 reports of a musty odor in Tylenol Arthritis Caplets, the FDA says the company didn’t initiate a formal investigation. McNeil spokeswoman Bonnie Jacobs said the company “is actively working in consultation with the FDA to address their concerns.”
On January 20, 2010, In Product Safety, By admin